BARK INC (BARK)

US68622E1047 - Common Stock

1.24  0 (0%)

After market: 1.25 +0.01 (+0.81%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BARK. BARK was compared to 126 industry peers in the Specialty Retail industry. The financial health of BARK is average, but there are quite some concerns on its profitability. BARK is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year BARK has reported negative net income.
BARK had a positive operating cash flow in the past year.
In the past 5 years BARK always reported negative net income.
BARK had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -14.44%, BARK is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -32.08%, BARK is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -14.44%
ROE -32.08%
ROIC N/A
ROA(3y)-17.3%
ROA(5y)-36.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 60.17%, BARK belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
In the last couple of years the Gross Margin of BARK has declined.
The Profit Margin and Operating Margin are not available for BARK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.58%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

BARK does not have a ROIC to compare to the WACC, probably because it is not profitable.
BARK has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BARK is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that BARK is in the distress zone and has some risk of bankruptcy.
BARK's Altman-Z score of 0.82 is on the low side compared to the rest of the industry. BARK is outperformed by 79.37% of its industry peers.
The Debt to FCF ratio of BARK is 2.33, which is a good value as it means it would take BARK, 2.33 years of fcf income to pay off all of its debts.
BARK has a better Debt to FCF ratio (2.33) than 69.84% of its industry peers.
BARK has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
BARK's Debt to Equity ratio of 0.28 is in line compared to the rest of the industry. BARK outperforms 57.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 2.33
Altman-Z 0.82
ROIC/WACCN/A
WACC7.5%

2.3 Liquidity

A Current Ratio of 2.65 indicates that BARK has no problem at all paying its short term obligations.
BARK has a better Current ratio (2.65) than 90.48% of its industry peers.
BARK has a Quick Ratio of 1.56. This is a normal value and indicates that BARK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BARK (1.56) is better than 84.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.56

4

3. Growth

3.1 Past

BARK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.28%, which is quite impressive.
The Revenue has decreased by -8.07% in the past year.
The Revenue has been growing by 33.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)51.28%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q58.33%
Revenue 1Y (TTM)-8.07%
Revenue growth 3Y33.64%
Revenue growth 5YN/A
Revenue growth Q2Q-6.87%

3.2 Future

BARK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.51% yearly.
The Revenue is expected to grow by 5.28% on average over the next years.
EPS Next Y60.58%
EPS Next 2Y34.61%
EPS Next 3Y28.74%
EPS Next 5Y20.51%
Revenue Next Year-7.4%
Revenue Next 2Y-1.94%
Revenue Next 3Y2.42%
Revenue Next 5Y5.28%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BARK. In the last year negative earnings were reported.
Also next year BARK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BARK indicates a somewhat cheap valuation: BARK is cheaper than 75.40% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.84
EV/EBITDA N/A

4.3 Compensation for Growth

BARK's earnings are expected to grow with 28.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.61%
EPS Next 3Y28.74%

0

5. Dividend

5.1 Amount

BARK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BARK INC

NYSE:BARK (5/17/2024, 7:04:01 PM)

After market: 1.25 +0.01 (+0.81%)

1.24

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap219.70M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.44%
ROE -32.08%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.17%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.65
Quick Ratio 1.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)51.28%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y60.58%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.07%
Revenue growth 3Y33.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y